Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von SpringheelJack 

Metlife Inc. diskutieren

Metlife Inc.

WKN: 934623 / Symbol: MET / Name: MetLife / Aktie / Versicherungen / Large Cap /

70,30 €
0,26 %

MetLife, Inc. (NYSE: MET) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,30 %
Kursziel 92,39
Veränderung
Endet am 06.01.26

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Barclays PLC from $90.00 to $96.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,82 %
Kursziel 84,94
Veränderung
Endet am 07.01.26

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at JPMorgan Chase & Co. from $86.00 to $88.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,47 %
Kursziel 89,35
Veränderung
Endet am 14.01.26

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Wells Fargo & Company from $93.00 to $92.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,10 %
Kursziel 91,98
Veränderung
Endet am 07.02.26

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Barclays PLC from $96.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,50 %
Kursziel 94,82
Veränderung
Endet am 12.02.26

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Keefe, Bruyette & Woods from $100.00 to $98.00. They now have an "outperform" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,06 %
Kursziel 92,96
Veränderung
Endet am 19.02.26

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Wells Fargo & Company from $92.00 to $97.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -15,35 %
Kursziel 104,68
Veränderung
Endet am 28.02.26

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Morgan Stanley from $101.00 to $109.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

MetLife, Inc. (NYSE: MET) had its "buy" rating re-affirmed by analysts at Cowen Inc.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -7,26 %
Kursziel 79,69
Veränderung
Endet am 02.04.26

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at JPMorgan Chase & Co. from $88.00 to $86.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -7,26 %
Kursziel 87,10
Veränderung
Endet am 02.04.26

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Piper Sandler from $92.00 to $94.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -7,26 %
Kursziel 90,81
Veränderung
Endet am 02.04.26

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at UBS Group AG from $94.00 to $98.00. They now have a "buy" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,25 %
Kursziel 86,12
Veränderung
Endet am 09.04.26

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Keefe, Bruyette & Woods from $98.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,85 %
Kursziel 85,66
Veränderung
Endet am 10.04.26

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Morgan Stanley from $109.00 to $94.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,85 %
Kursziel 82,93
Veränderung
Endet am 10.04.26

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Wells Fargo & Company from $97.00 to $91.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 11,69 %
Kursziel 78,01
Veränderung
Endet am 11.04.26

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Barclays PLC from $95.00 to $88.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,60 %
Kursziel 83,23
Veränderung
Endet am 06.05.26

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Wells Fargo & Company from $91.00 to $94.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,60 %
Kursziel 88,59
Veränderung
Endet am 19.05.26

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Morgan Stanley from $94.00 to $99.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,02 %
Kursziel 79,84
Veränderung
Endet am 07.07.26

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Barclays PLC from $88.00 to $94.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,36 %
Kursziel 80,92
Veränderung
Endet am 08.07.26

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at JPMorgan Chase & Co. from $86.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat